OXGENE
Michal Fleszar is an AAV Scientist at OXGENE since December 2021, specializing in the analytical aspects of viral vector manufacturing processes. Prior experience includes roles as an Industrialisation Technician at Cell and Gene Therapy Catapult, focusing on robust manufacturing processes, and a Research Scientist Intern at Oxford Nanopore Technologies Ltd, where investigations centered on novel protein pores and purification methods. Academic background includes a Bachelor's degree in Molecular Microbiology from the University of Dundee, complemented by research internships at the University of Oxford and EMBL, engaging in protein purification and structural studies of pathogen-associated proteins, as well as the investigation of chromosomal dynamics during meiosis.
This person is not in any teams
OXGENE
OXGENE redefines possible in mammalian cell engineering. Their technology platforms and expert solutions accelerate the discovery, development and manufacture of cell and gene therapies.